Centene Corporation (CNC) Director Robert K. Ditmore Sells 4,167 Shares

Centene Corporation (NYSE:CNC) Director Robert K. Ditmore sold 4,167 shares of the company’s stock in a transaction dated Thursday, July 27th. The shares were sold at an average price of $82.59, for a total transaction of $344,152.53. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Robert K. Ditmore also recently made the following trade(s):

• On Friday, June 2nd, Robert K. Ditmore sold 3,900 shares of Centene Corporation stock. The shares were sold at an average price of $75.43, for a total transaction of $294,177.00.

Centene Corporation (CNC) opened at 82.69 on Monday. The company has a market cap of $14.26 billion, a price-to-earnings ratio of 18.15 and a beta of 0.67. The company’s 50-day moving average is $81.36 and its 200 day moving average is $73.20. Centene Corporation has a 12 month low of $50.00 and a 12 month high of $87.94.

Centene Corporation (NYSE:CNC) last released its earnings results on Tuesday, July 25th. The company reported $1.59 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.30 by $0.29. The firm had revenue of $11.95 billion for the quarter, compared to analysts’ expectations of $11.69 billion. Centene Corporation had a return on equity of 14.62% and a net margin of 1.72%. The business’s quarterly revenue was up 9.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.29 EPS. Equities analysts forecast that Centene Corporation will post $4.87 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece of content was originally published by [[site]] and is the sole property of of [[site]]. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at [[permalink]].

A number of large investors have recently added to or reduced their stakes in the stock. Quadrant Capital Group LLC boosted its stake in Centene Corporation by 5.6% in the first quarter. Quadrant Capital Group LLC now owns 2,263 shares of the company’s stock valued at $155,000 after buying an additional 120 shares during the last quarter. Gulf International Bank UK Ltd boosted its stake in shares of Centene Corporation by 1.8% in the first quarter. Gulf International Bank UK Ltd now owns 51,917 shares of the company’s stock worth $3,699,000 after buying an additional 900 shares in the last quarter. Chesley Taft & Associates LLC boosted its stake in shares of Centene Corporation by 12.9% in the first quarter. Chesley Taft & Associates LLC now owns 5,352 shares of the company’s stock worth $381,000 after buying an additional 610 shares in the last quarter. Creative Planning boosted its stake in shares of Centene Corporation by 5.4% in the first quarter. Creative Planning now owns 2,476 shares of the company’s stock worth $176,000 after buying an additional 127 shares in the last quarter. Finally, Raymond James Trust N.A. boosted its stake in shares of Centene Corporation by 3.2% in the first quarter. Raymond James Trust N.A. now owns 4,451 shares of the company’s stock worth $318,000 after buying an additional 139 shares in the last quarter. Hedge funds and other institutional investors own 93.60% of the company’s stock.

A number of analysts have commented on the stock. Morgan Stanley assumed coverage on shares of Centene Corporation in a research note on Tuesday, June 6th. They set an “overweight” rating and a $86.00 price objective for the company. Citigroup Inc. upped their price objective on shares of Centene Corporation from $80.00 to $89.00 and gave the company a “sell” rating in a research note on Wednesday, July 26th. ValuEngine lowered shares of Centene Corporation from a “buy” rating to a “hold” rating in a research note on Tuesday, June 13th. Stifel Nicolaus increased their price target on shares of Centene Corporation from $80.00 to $85.00 and gave the stock a “buy” rating in a research report on Wednesday, April 26th. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $90.00 price target on shares of Centene Corporation in a research report on Tuesday, July 25th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $86.82.

Centene Corporation Company Profile

Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.